Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever
about
Subversion of innate defenses by the interplay between DENV and pre-existing enhancing antibodies: TLRs signaling collapseExtensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infectionFever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public healthInhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomersDengue and dengue hemorrhagic feverAn in-depth analysis of original antigenic sin in dengue virus infectionThe global distribution of yellow fever and dengueDengue: defining protective versus pathologic immunityThe dengue virusesPathogenesis of human immunodeficiency virus infectionDengue virus pathogenesis: an integrated viewNeutralizing antibodies after infection with dengue 1 virusRole of dendritic cells in antibody-dependent enhancement of dengue virus infectionDC-SIGN (CD209) mediates dengue virus infection of human dendritic cellsHuman antibody responses after dengue virus infection are highly cross-reactive to Zika virusHuman antibody response to dengue virus: implications for dengue vaccine designDegrees of maturity: the complex structure and biology of flavivirusesRole of microparticles in dengue virus infection and its impact on medical intervention strategiesMouse models to study dengue virus immunology and pathogenesisCirculating serotypes of dengue virus and their incursion into non-endemic areas of Pakistan; a serious threatPrM- and cell-binding domains of the dengue virus E protein.Infection of human cells by dengue virus is modulated by different cell types and viral strainsChimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell responseDengue virus structural differences that correlate with pathogenesis.Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine.Specific ablation of antiviral gene expression in macrophages by antibody-dependent enhancement of Ross River virus infection.Dynamic effects of antibody-dependent enhancement on the fitness of virusesInvasion and Maintenance of Dengue Virus Type 2 and Type 4 in the AmericasSuppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-kappa B) complexes by antibody-dependent enhancement of macrophage infection by Ross River virusYellow Fever Virus/Dengue-2 Virus and Yellow Fever Virus/Dengue-4 Virus Chimeras: Biological Characterization, Immunogenicity, and Protection against Dengue Encephalitis in the Mouse ModelAmerican Genotype Structures Decrease Dengue Virus Output from Human Monocytes and Dendritic CellsThe effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogensEcological and immunological determinants of dengue epidemicsDifferential Enhancement of Dengue Virus Immune Complex Infectivity Mediated by Signaling-Competent and Signaling-Incompetent Human Fc RIA (CD64) or Fc RIIA (CD32)Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and PathogenesisAntibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope ProteinAdvances in dengue diagnosisVirus-Induced Decline in Soluble Vascular Endothelial Growth Receptor 2 Is Associated with Plasma Leakage in Dengue Hemorrhagic FeverActivation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytesSecreted NS1 of Dengue Virus Attaches to the Surface of Cells via Interactions with Heparan Sulfate and Chondroitin Sulfate E
P2860
Q21144516-EB2010D8-32EB-4421-A79B-168A0F95CC3CQ21245045-86DECACC-6D7C-436E-9B48-48D19741E4AAQ24289308-2B97AA10-B8C7-4ECE-964C-25CC4AE2D998Q24520621-197722F3-A350-4849-A44B-5B5531E6DC06Q24550739-17B6C6B4-0C32-4E74-BA3D-6B032DB5ABFAQ24606493-4F3B6722-04CB-4B93-A084-AF02B48487C1Q24607960-F3EFC9A1-732C-4AE8-A961-D964A246636AQ24609884-78B8B876-6626-4766-B179-8FABBC755C92Q24616798-A21842C8-8007-49C7-875A-F62CC2C6F2CAQ24634681-C50B234C-12ED-4A76-87C3-3898259A762BQ24645380-85823BD1-06A8-4763-A406-97064C26059DQ24652746-ADE7A528-C5FD-45A1-AD14-BEBC3998EDE5Q24655655-43FFE5B9-A41B-4B5E-ABB5-A98D49CBE611Q24673466-CE519F74-3CA9-45B4-B7B5-9F7161376923Q25161212-891445F3-AA61-49D7-B64B-C60D7EF2A46DQ26314609-EF190BCC-A4E3-4700-A00C-C4FA898C654EQ26824712-C60EE38D-0E84-4E34-9EAC-EF65C1EEA7E8Q26860307-47AC8AC1-AE5E-4EFA-A4D4-C4774F875B6DQ27010151-A1BE1559-03D6-4A61-8B9F-53EA7CE3C6C3Q27468814-CDF2D669-FBDE-4F3E-8B6E-0D7C19B53EE8Q27469382-EFEFA1E8-1F73-4B87-B3B6-43C721C6D5C7Q27469687-B176DA7D-EA0A-4DD3-AD53-48BF7AA7626AQ27469691-74EB476F-4B32-45A0-869A-DF655B04A4DEQ27469705-8324388E-CB0B-4C25-AA60-81A49B8ED8D7Q27469921-EC460D7A-67DF-4435-87EA-D50ED0641E0BQ27470004-50EF6324-2BDE-48A5-9360-0DB55EFBFA14Q27472667-8F09AA2D-CCEF-4395-8D9C-215077C52AB2Q27472713-68031340-BFFD-4197-AA54-EC6625A3D26BQ27472728-2FF618C5-0FDA-4966-90FC-F6E6048CE0BDQ27473317-F6DD1BD9-4005-4AA9-A235-EF6CB33A9B7EQ27473379-48CF627E-8291-4656-A99F-FDFFC9D9ED85Q27473404-4310C8DB-DAC2-46E0-BE5D-9367F29C3751Q27473480-BE00392A-4C23-4A25-B752-E660D54F2294Q27477546-4F6C9FBA-8419-43FD-9234-3BEF311342A6Q27477646-2DF800BB-7ABA-4085-BF10-0409FDA5FBEEQ27477718-EC6CF281-1E75-4F36-B586-EBBBF4E60B64Q27477784-C76B821E-736A-471E-A96E-7B6D2864BDC7Q27478050-F561F0D9-BFB3-4530-BD40-931B40D328AEQ27480826-9E0130C2-519A-4BCB-85A8-B8AA15E35883Q27481677-B55466EF-4020-4205-A1BC-A710DC9C7BD7
P2860
Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever
description
1989 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1989
@ast
scientific article (publication date: April 1989)
@en
wetenschappelijk artikel (gepubliceerd in 1989-04)
@nl
наукова стаття, опублікована у квітні 1989
@uk
مقالة علمية (نشرت في أبريل 1989)
@ar
name
Antibody-dependent enhancement ...... r for dengue hemorrhagic fever
@ast
Antibody-dependent enhancement ...... r for dengue hemorrhagic fever
@en
type
label
Antibody-dependent enhancement ...... r for dengue hemorrhagic fever
@ast
Antibody-dependent enhancement ...... r for dengue hemorrhagic fever
@en
prefLabel
Antibody-dependent enhancement ...... r for dengue hemorrhagic fever
@ast
Antibody-dependent enhancement ...... r for dengue hemorrhagic fever
@en
P2093
P921
P3181
P1476
Antibody-dependent enhancement ...... r for dengue hemorrhagic fever
@en
P2093
P304
P3181
P407
P577
1989-04-01T00:00:00Z